Skip to main content
All lobbying filings

VALNEVA USA, INC.

Lobbying for VALNEVA USA, INC. · Vaccine company

 Filing 4th Quarter - Termination
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $120,000.00 expenses · posted Dec 4, 2025

Official filing document

 Lobbying activity 1
Health Issues

Coverage for all adult vaccines (regulation related to Public Health Service Act, Sec 2713); Appropriations related to CDC report on arbovirus threat; Appropriations related to funding the State Stockpile Grant program; Issues related to Strategic National Stockpile procurement regarding new emerging infection diseases and in relation to the Preparedness Act (PAHPA) reauthorization; Issues related to the FDA's Priority Review Voucher; Issues related to reauthorization of the publican health emergency medical countermeasures enterprise; Enhancing immunization access for military dependents

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem